Inaugural Session
Express Pharma recently organised the Goa Pharma Summit 2024 with a vision to co-create an ecosystem that nurtures innovation, excellence, and growth within the pharma industry.
This summit brought together leaders, innovators, and experts from the state's pharma sector to discuss Goa's pivotal role as a major hub for pharma production and research.
The Summit served as a platform for experts to converse on critical topics shaping the future of pharmaranging from advancements in technology and innovation strategies to navigating regulatory landscapes and fostering sustainability.
The event also offered opportunities galore for networking and interaction.
It commenced with a ceremonial lamplighting and a welcome address by Express Pharma, setting the tone for knowledge exchange.
Innovations in active packaging
Dhairy Sharma, Sr Executive Business Development, Cilicant, delivered an engaging presentation on 'Innovations in active packaging' at the Goa Pharma Summit 2024. He highlighted cutting-edge developments in active packaging technology and their impact on the pharma industry. Sharma also pointed out how these advancements play a crucial role in maintaining product stability, extending shelf life, and enhancing patient safety.
The presentation accentuated the increasing relevance of intelligent active packaging solutions, and detailed how Cilicant's offerings address the industry's evolving needs. Sharma also provided a comprehensive overview of active packaging's function: not onlprotecting contents and interacting with them to preserve efficacy and safety.
Esta historia es de la edición October 2024 de Express Pharma.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición October 2024 de Express Pharma.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Pharma's strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.
PRIME NEO from Gandhi Automations
Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable
AI smart camera for real-time automation
Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
Complete environmental monitoring solution - testo Saveris Pharma
testo Saveris Pharma monitors and documents temperature, humidity, differential pressure, and other parameters without interruption and compliantly with GxP so that audits and inspections are conducted smoothly
The unmissable Asia healthcare opportunity
BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.
2025: Healthcare and Lifesciences investment outlook
Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year
The group's offerings range from over a billion injection doses annually to bespoke medical machinery
Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.
DECODING THE M&A LANDSCAPE
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.
